cbdMD

YCBD · NYSE American

$0.3873+$0.0392 (+11.26%)TodayMarket closed ·
Prev close $0.3481

Latest news

  • Press releasePRNewswire

    Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation

  • Press releasePRNewswire

    cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness

  • News

    cbdMD Q3 2026 Earnings Call: Complete Transcript

  • Press releasePRNewswire

    cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

  • Press releasePRNewswire

    cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results

  • Press releasePRNewswire

    cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • Press releasePRNewswire

    cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access

  • Press releasePRNewswire

    cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina

  • Press releasePRNewswire

    cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation

  • Press releasePRNewswire

    cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination

  • Press releasePRNewswire

    Oasis Launches Hemp-Derived Mixer

  • Press releasePRNewswire

    cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products

  • Press releasePRNewswire

    cbdMD Appoints Wade Brown Chief Marketing Officer

  • News

    Full Transcript: cbdMD Q2 2026 Earnings Call

  • Press releasePRNewswire

    cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

  • News

    Earnings Scheduled For May 14, 2026

  • Press releasePRNewswire

    cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results

  • Press releaseBusiness Wire

    Hawkeye Systems Announces New Board Members With Deep Capital Markets, Governance, Legal, and Merchant Banking Experience

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Why United Rentals Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

  • Press releasePRNewswire

    cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

  • Press releasePRNewswire

    cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

  • News

    Earnings Outlook For cbdMD

  • Press releasePRNewswire

    cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

  • Press releasePRNewswire

    cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum

  • Press releasePRNewswire

    cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways

  • Press releasePRNewswire

    cbdMD Announces Strategic Acquisition of Bluebird Botanicals

  • NewsRishabh Mishra

    Stock Market Today: Dow Jones, S&P 500 Futures Climb At The Start Of Christmas Week— Kemper, Trump Media & Technology, cbdMD In Focus (UPDATED)

  • Press releasePRNewswire

    cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance

  • Press releasePRNewswire

    cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement

  • News

    cbdMD Shares Halted, News Pending

  • NewsAvi Kapoor

    Why Oracle Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

  • Press releaseNewsfile

    cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter

  • Press releaseNewsfile

    cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

  • Press releaseNewsfile

    cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

  • Press releaseNewsfile

    cbdMD Generates $5.1 Million in Revenue, Positive Earnings

  • Press releaseNewsfile

    cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement

  • Press releaseNewsfile

    cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.